LOX and Hepatic fibrosis: A previous study performed in a model of TAA-induced experimental liver fibrosis has explored the specific contribution of LOX and LOXL2 to fibrotic matrix stabilization utilizing specific blocking mAbs (M64 and AB0023, respectively) (12).